- Report
- August 2024
- 250 Pages
Global, Europe, United States, ... Global, Europe, United States, Japan
From €2230EUR$2,450USD£1,912GBP
- Report
- November 2021
- 119 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- April 2024
- 140 Pages
Global
From €4504EUR$4,949USD£3,861GBP
- Report
- August 2024
- 56 Pages
Spain
From €3413EUR$3,750USD£2,926GBP
- Report
- August 2024
- 57 Pages
Italy
From €3413EUR$3,750USD£2,926GBP
- Report
- November 2024
Japan, United States, ... Japan, United States, Europe
From €1320EUR$1,450USD£1,131GBP
- Report
- October 2024
Global
From €3185EUR$3,500USD£2,731GBP
- Company Profile
- September 2024
From €1320EUR$1,450USD£1,131GBP
- Company Profile
- September 2024
From €865EUR$950USD£741GBP
- Report
- August 2024
- 61 Pages
Germany
From €3413EUR$3,750USD£2,926GBP
- Report
- August 2024
- 58 Pages
France
From €3413EUR$3,750USD£2,926GBP
- Report
- August 2024
- 101 Pages
United States
From €3413EUR$3,750USD£2,926GBP
- Report
- August 2024
- 64 Pages
United Kingdom
From €3413EUR$3,750USD£2,926GBP
- Report
- March 2022
Japan, United States, ... Japan, United States, Europe
From €1320EUR$1,450USD£1,131GBP

The Carcinoembryonic Antigen (CEA) Test is a diagnostic tool used to detect the presence of CEA in the blood. CEA is a protein produced by certain types of cancer cells, and its presence in the blood can indicate the presence of cancer. The CEA Test is used to monitor the progression of cancer, as well as to detect recurrence after treatment. It is also used to detect the presence of certain types of cancer in individuals who have no symptoms.
The CEA Test market is a subset of the larger Diagnostics market, which includes a wide range of tests used to diagnose and monitor diseases. The CEA Test market is a growing segment of the Diagnostics market, as it is increasingly used to detect and monitor cancer.
Some companies in the CEA Test market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, and Quest Diagnostics. Show Less Read more